Wendy Oakden1 and Greg J Stanisz1,2,3
1Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada, 2Medical Biophysics, University of Toronto, Toronto, ON, Canada, 3Neurosurgery and Paediatric Neurosurgery, Medical University of Lublin, Lublin, Poland
Synopsis
Changes
in metabolite levels as a result of treatment can be quite small. This study
investigated the variability of MRS detectable metabolites so that the effects
relating to the treatment would not be confounded by other experimental factors.
A four-way ANOVA was used to separate the
effects of differences in housing conditions (single housing, pairs, or
enriched environment) as well as age (5-15 weeks), strain (Long Evans vs
Sprague Dawley), and SNR. Significant changes in MRS were observed due to age,
strain, and SNR, but any changes due to housing conditions were small in
comparison.
Introduction
Longitudinal magnetic resonance spectroscopy (MRS)
experiments often involve treatments which require rats to be housed separately
rather than in pairs. The changes in MRS detectable metabolites can be quite
small. In order to quantify them it is important to minimize or control for as
many other variables as possible, so that the effects relating to the treatment are not confounded by other experimental factors. The purpose of this study
was to investigate the variability in MRS resulting from housing conditions (rats
housed either singly in a normal cage, in pairs in a normal cage, or in pairs
in an enriched environment), age, strain, and signal to noise ratio (SNR).Methods
12 male Sprague Dawley (SD) rats, age 5-11 weeks, and 24
male Long Evans (LE) rats, aged 7-15 weeks, initially kept in pairs in normal
cages, were housed either singly (n=12), in pairs in a normal cage (n=12), or
in pairs in an enriched cage (n=12). MRS was obtained 0, 2, 4, and 6 weeks
following the change in housing, in both cortex and hippocampus using a PRESS
sequence: TE/TR 16/2500ms, 600 averages, 2048 points, 4kHz bandwidth, voxel
size 3.5x1.25x4.0 mm3 (cortex) or 4.5x1.4.x2.0 mm3 (hippocampus).
MRS spectra were analyzed using LCModel1 with a basis set generated
using the
Magnetic Resonance Spectrum Simulator2 (MARSS) and a measured macromolecular
baseline. Metabolites
were selected for further analysis based on having at least 20% of their Cramer
Rao Lower Bounds < 20, and those with significant negative correlations were
combined. A four-way analysis of variance (ANOVA) was used to separate the
effects of age, strain, SNR, and housing type where age was
measured in weeks, strain referred to LE or SD, and SNR was split into
quartiles. Effects with p-values < 0.05 following Bonferroni correction were
considered to be statistically significant.Results
The following metabolites and combinations were
selected for analysis: Ascorbate (Asc), aspartate (Asp), γ-aminobutyric acid (GABA), glucose (Glc),
glutamine (Gln), glutamate (Glu), glutathione (GSH), N-acetyl aspartate
(NAA), phosphoethanolamine (PE), taurine (Tau), macromolecules (MMB), glycerophosphocholine
+ phosphocholine (tPCh), myo-inositol + glycine (Ins+Gly), and creatine +
phosphocreatine (tCr). ANOVA results are shown in Figure 1, where the y-axis has
been inverted so that statistical significance will be easier to observe. There
was no significant effect of housing on any of the metabolites investigated.
Age, strain, and SNR all had significant effects which varied depending on
brain region and metabolite. Significant effects of SNR on metabolite
concentrations were primarily slight decreases in concentration as SNR
increased, except for NAA which increased slightly with SNR (from 8.1±0.7mM
to 8.4±0.3mM in
cortex, and from 7.7±0.4mM to 8.0±0.3mM in hippocampus). Total
creatine was similar between strains, but did increase with age in the cortex
(Fig. 2). NAA increased with age in both regions, and was also higher in SD
than in LE (Fig. 3). Glutamate showed an increase with age in the LE rats, but
had a different pattern of increase in the SD rats (Fig. 4). Table 1 shows concentrations at 11 weeks for
all metabolites analyzed in both brain regions and both strains.Discussion
While it remains possible that there are subtle effects of
different types of rat housing that are observable on MRS, any such effects
were overwhelmed by the variability in other experimental parameters. Due to
logistical constraints, experiments were conducted on groups of 12 animals at a
time. The original plan was to start scanning each cohort at the same age (5
weeks), however technical problems prevented the 2nd & 3rd
sets of experiments from starting on time. Several metabolites were present in
very different concentrations in the 5 week old SD rats, however postponing the
start of the experiment until they were 7 weeks old would have caused a
different problem: by 11 weeks of age these rats averaged 550±33g,
and by 13 weeks some of them may have been too large to fit in the bore of the
scanner. The LE rats grow more slowly and were only 410±36g at 11 weeks, making it
more feasible to conduct a long experiment.
The differences in measured concentration resulting from
changes in SNR are most likely due to the improved overall detection of
metabolites at higher SNR. Increasing SNR will have the greatest effect on the
ability of algorithms like LCModel to quantify metabolites with complicated
spectra and significant overlap with other spectra. In this study, all of the
metabolites which showed significant decreases in measured concentration with
increasing SNR had relatively complex spectra. The only metabolite which
increased in concentration with increasing SNR was NAA, likely due to
corresponding decreases in the measured concentration of Glu, Gln and GSH which
all have complex spectra overlapping that of NAA.Conclusions
Any changes in MRS due to differences in housing conditions
in rats are small in comparison to those resulting from differences in age,
strain, and SNR. When planning longitudinal studies, it is critically important
to control for as many factors as possible, and control groups are of
particular importance as changes in neurochemistry with age mean that baseline
measurements cannot be used to control for differences between treatment
groups. Acknowledgements
Funding for this project was provided by the Canadian Institutes of Health Research CIHR: PJT 148660References
1. Provencher SW.
Estimation of metabolite concentrations from localized in vivo proton NMR
spectra. Magn Reson Med. 1993;30(6):672-679. doi:10.1002/mrm.1910300604.
2. Landheer K, Swanberg KM, Juchem C.
Magnetic resonance Spectrum simulator (MARSS), a novel software package for
fast and computationally efficient basis set simulation. NMR Biomed.
2019;(May):1-13. doi:10.1002/nbm.4129.